CDER’s Woodcock Retiring? Rumors Never Go On Furlough
Executive Summary
On day 10 of the federal government shutdown, a Reuters story sparks concern inside and outside the agency that FDA’s drugs center director could soon retire without an obvious successor waiting in the wings; Woodcock fires back with a memo assuring CDER staff she has no plans to leave.
You may also be interested in...
Janet Woodcock Retires From US FDA: ‘I’m Trying To Tie Up All The Loose Ends’
On the eve of departure after more than 37 years of service to FDA, the agency’s principal deputy commissioner discusses her legacy, issues that others will take up, and preparing the agency for change in a Pink Sheet interview.
Janet Woodcock Retires From US FDA: ‘I’m Trying To Tie Up All The Loose Ends’
On the eve of departure after more than 37 years of service to FDA, the agency’s principal deputy commissioner discusses her legacy, issues that others will take up, and preparing the agency for change in a Pink Sheet interview.
With Woodcock’s Retirement, US FDA Loses A Renaissance Woman
FDA will go on without Janet Woodcock, but it will likely take multiple people to fill in the gaps given her breadth of institutional knowledge, interests and skill sets, former close colleagues say.